Loading clinical trials...

Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty | Clinical Trials | Clareo Health

WITHDRAWNPhase 4NCT05157464

Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty

Recent research has focused on methods to mitigate scar tissue formation and arthrofibrosis following surgery in hopes that patients may attain maximal range of motion goals, avoid manipulation and se...

Lead sponsor: NYU Langone Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETED

A Prospective Clinical Trial Comparing Serum Mast Cell Tryptase (SMCT) Levels to Arthrofibrosis Rates Among Primary Total Knee Arthroplasty (TKA) Patients

NCT03598829 · Knee Osteoarthritis, Arthropathy of Knee, and more

COMPLETEDNA

Werewolf Flow 50 During ACL Reconstruction

NCT04998656 · Anterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, and more

UNKNOWN

Ultrasound Imaging of Fibrotic Tissue

NCT05818904 · Arthrofibrosis of Knee, Arthrofibrosis of Shoulder

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 1, 2023Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE4

Enrollment—

Start dateSep 2023

Last updatedDec 1, 2023

Condition

Arthrofibrosis

Locations shown

NYU Langone Health

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 1, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions